Biogen
Price & Volume
Stats
See more52W Range | $110.04-$185.17 |
Market Cap | $25.9B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $10B |
Revenue Growth (YoY) | 2.8% |
Gross Profit (12 Mos) | $7.7B |
Diluted EPS | $10.97 |
News
See moreYahoo Finance • 2 hours ago
Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
Yahoo Finance • 20 hours ago
Stocks Climb as Technology Shares Rebound
Yahoo Finance • 21 hours ago
Stocks Supported by Strength in Tech and Fed Rate Cut Expectations
Yahoo Finance • yesterday
Novo Dives After Weight-Loss Pill Fails In Alzheimer's Disease; Biogen Jumps
About
CEO | Mr. Christopher A. Viehbacher |
CFO | Ms. Robin C. Kramer |
Address | 225 Binney Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 7,605 |
